These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2587854)

  • 21. [The Italian experience in the control of rabies. I. Procedural methods].
    Ruatti A; Ponzanelli M; Allegretti M; Mengon F; Costanzi C
    Parassitologia; 1988; 30(1):19-28. PubMed ID: 3268768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rabies in Austria 1966-1986].
    Scharfen E
    Parassitologia; 1988; 30(1):81-5. PubMed ID: 3268777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the delivery of oral rabies vaccines to wildlife and dog populations.
    Perry BD; Johnston DH; Jenkins SR; Foggin CM; Garner N; Brooks R; Bleakley J
    Acta Vet Scand Suppl; 1988; 84():303-5. PubMed ID: 3232627
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral immunization against rabies: afterthoughts and foresight.
    Wandeler AI
    Schweiz Arch Tierheilkd; 2000 Aug; 142(8):455-62. PubMed ID: 11004894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and significance of tetracycline stability in rabies vaccine baits.
    Johnston JJ; Primus TM; Buettgenbach T; Furcolow CA; Goodall MJ; Slate D; Chipman RB; Snow JL; DeLiberto TJ
    J Wildl Dis; 2005 Jul; 41(3):549-58. PubMed ID: 16244065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to the prevention and eradication of rabies.
    Dietzschold B; Faber M; Schnell MJ
    Expert Rev Vaccines; 2003 Jun; 2(3):399-406. PubMed ID: 12903805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabies virus vaccines.
    Schneider LG
    Dev Biol Stand; 1995; 84():49-54. PubMed ID: 7796967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrosequencing of the rabies virus glycoprotein gene to demonstrate absence of vaccine-associated rabies cases following oral vaccination.
    De Benedictis P; De Battisti C; Marciano S; Mutinelli F; Capua I; Cattoli G
    Vet J; 2013 Mar; 195(3):388-90. PubMed ID: 22841448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
    Rupprecht CE; Hanlon CA; Slate D
    Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep.
    DeMartini JC; Bickle HM; Brodie SJ; He BX; Esposito JJ
    Arch Virol; 1993; 133(1-2):211-22. PubMed ID: 8240013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.
    Charlton KM; Artois M; Prevec L; Campbell JB; Casey GA; Wandeler AI; Armstrong J
    Arch Virol; 1992; 123(1-2):169-79. PubMed ID: 1550495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological survey for orthopoxvirus infection of wild mammals in areas where a recombinant rabies virus is used to vaccinate foxes.
    Boulanger D; Crouch A; Brochier B; Bennett M; Clément J; Gaskell RM; Baxby D; Pastoret PP
    Vet Rec; 1996 Mar; 138(11):247-9. PubMed ID: 8734505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of vaccinia rabies recombinant for oral vaccination of wildlife.
    Desmettre P; Languet B; Chappuis G; Brochier B; Thomas I; Lecocq JP; Kieny MP; Blancou J; Aubert M; Artois M
    Vet Microbiol; 1990 Jun; 23(1-4):227-36. PubMed ID: 2205969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination as a triggering agent for the development of rheumatoid arthritis.
    Sharma A; Agarwal D; Kapoor S; Garg SR; Malaviya AN
    Int J Rheum Dis; 2011 Feb; 14(1):e8-9. PubMed ID: 21303474
    [No Abstract]   [Full Text] [Related]  

  • 35. Rabies epidemiology, natural barriers and fox vaccination.
    Wandeler AI; Capt S; Gerber H; Kappeler A; Kipfer R
    Parassitologia; 1988; 30(1):53-7. PubMed ID: 3268773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rabies. II. Epidemiological situation in the Americas. Vaccines and immunity].
    Dellepiane NI; Díaz AM
    Rev Argent Microbiol; 1987; 19(3):125-38. PubMed ID: 2459728
    [No Abstract]   [Full Text] [Related]  

  • 37. New approaches to the development of live attenuated rabies vaccines.
    Dietzschold B; Schnell MJ
    Hybrid Hybridomics; 2002 Apr; 21(2):129-34. PubMed ID: 12031103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France.
    Aubert MF; Masson E; Artois M; Barrat J
    Curr Top Microbiol Immunol; 1994; 187():219-43. PubMed ID: 7859492
    [No Abstract]   [Full Text] [Related]  

  • 39. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 40. An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada.
    Sobey KG; Walpole AA; Rosatte R; Fehlner-Gardiner C; Donovan D; Bachmann P; Coulson S; Beresford A; Bruce L; Kyle CJ
    Vaccine; 2013 Apr; 31(17):2207-13. PubMed ID: 23499602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.